secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pelthos Therapeutics Inc. (PTHS)
CIK:        0001919246
Form:       8-K
Filed at:   2025-05-01T23:59:59+00:00
Accession:  0001753926-25-000722
Event type: regulatory
Sentiment:  negative
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Channel Therapeutics issues NYSE American-required announcement on going concern in 2024 10-K
--------------------------------------------------------------------------------

- 2024 10-K audit opinion includes a going concern emphasis of matter (previously filed March 27, 2025).
- Press release issued May 1, 2025 to comply with NYSE American Sections 401(h) and 610(b).
- Announcement does not change or amend the audited financial statements or the 2024 10-K.
- Company develops non-opioid pain therapeutics (no new business updates).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1919246/000175392625000722/0001753926-25-000722-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1919246/000175392625000722/g084795_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-25-000722

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer